Yamuna Devi Bakthavatchalam, Fizaa Abdullah, Devishree Srinivasan, Sangeetha Nithiyanandam, Ayyanraj Neeravi, Poojah Shah, Nivedhana Subburaju, Subha Vajjiravelu Jaganathan, Rema Devi, Gita Nataraj, Binesh Lal Yesudason, Kamini Walia, Balaji Veeraraghavan
BACKGROUND: There is a high diversity of beta-lactamases in gram negative pathogens, making them difficult to treat. In the presence of OXA-1 and ampC, PTZ is no longer clinically relevant when treating Enterobacterales expressing ESBLs. Further, MBL infections are often treated with ceftazidime/avibactam and aztreonam in combination. It has recently been reported that NDM-expressing E. coli isolates co-harboring NDM developed resistance to this triple combination. METHODS: The pentaplex PCR is developed and validated to detect blaCTX-M , blaOXA-1 , blaCMY , blaNDM , and the PBP3 insert in whole genome sequenced isolates...
August 22, 2024: Indian Journal of Medical Microbiology